Diffuse Fibrotic Lung Disease

NCT00000596 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Lung Diseases
Pulmonary Fibrosis
Sarcoidosis

Interventions

DRUG: prednisone
DRUG: cyclophosphamide
DRUG: dapsone

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)